Travere Therapeutics, Inc. Profile Avatar - Palmy Investing

Travere Therapeutics, Inc.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of cheno…

Biotechnology
US, San Diego [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of TVTX's Analysis
CIK: 1438533 CUSIP: 89422G107 ISIN: US89422G1076 LEI: - UEI: -
Secondary Listings
TVTX has no secondary listings inside our databases.